FDA Biologics (BLA & Biosimilars)Original article
FDA Scientific Public Workshop: Next-Generation Sequencing for Adventitious Agent Detection in Biologics – September 23, 2026 - 09/23/2026
ConferenceNeutral
AI Analysis
Summary
The FDA held a scientific workshop on September 23, 2026 to discuss the readiness and adoption of next-generation sequencing technologies for detecting adventitious agents in biological products, bringing together subject matter experts and stakeholders.
Importance:2/10
Sentiment:
0.00
FDA workshopnext-generation sequencingadventitious agent detectionbiologicsregulatory
Related Companies
Read the original article
Published by FDA Biologics (BLA & Biosimilars) on September 25, 2026 6:47 PM